New data reflects success of non-invasive heart procedures
- FFRangio technology shows promising results in heart procedures
- Study involves over 4,000 patients across the U.S.
- Outcomes comparable to traditional invasive techniques
A recent clinical trial presented late-breaking data on the CathWorks FFRangio technology, marking a significant milestone in non-invasive heart procedures. This study involved over 4,000 patients in the U.S. and aimed to evaluate the technology's effectiveness in comparison to traditional invasive pressure wire-guided percutaneous coronary intervention (PCI). Findings suggest that the clinical outcomes for FFRangio patients are favorable, maintaining effectiveness up to two years post-procedure.
The presentation of this data indicates that the CathWorks FFRangio method could serve as a viable alternative for patients requiring evaluation of coronary artery disease. This non-invasive approach has shown results comparable to those achieved through standard invasive methods. As heart health remains a critical area of concern, continued analysis of such technologies is essential for improving patient care.
Overall, the findings from this large cohort highlight the potential of FFR technology to enhance the options available for managing heart health. With similar outcomes to conventional methods, it may represent a step forward in reducing the need for more invasive interventions.
